Natixis’s Allergan Inc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CA
ECM
HFS
AIM
Natixis's AGN Position: Q1 2015 in Review
Natixis sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 176,700 shares — an estimated $37.6M sold.
Natixis first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $73.2M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.
- Natixis reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
- Natixis sold 176,700 Allergan Inc shares in Q1 2015, an estimated $37.6M.
- Natixis first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
- Natixis's Allergan Inc position peaked at $73.2M in Q1 2014.
- 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.
Based on Natixis's 13F filing for Q1 2015, filed 22 May 2015.